Company page

Acumen Pharmaceuticals, Inc.

Acumen Pharmaceuticals, Inc. (ticker: ABOS) is a public company based in the United States, with a market capitalization of approximately $162.5 million. The company focuses on developing innovative therapies for neurodegenerative diseases. Acumen aims to address significant unmet medical needs in the field of Alzheimer's disease and related conditions.